Novartis Balance Sheet Health
Financial Health criteria checks 4/6
Novartis has a total shareholder equity of $43.4B and total debt of $30.3B, which brings its debt-to-equity ratio to 69.8%. Its total assets and total liabilities are $103.5B and $60.1B respectively. Novartis's EBIT is $18.3B making its interest coverage ratio 57.1. It has cash and short-term investments of $13.9B.
Key information
69.8%
Debt to equity ratio
US$30.32b
Debt
| Interest coverage ratio | 57.1x |
| Cash | US$13.85b |
| Equity | US$43.44b |
| Total liabilities | US$60.08b |
| Total assets | US$103.52b |
Recent financial health updates
No updates
Recent updates
What To Expect When Novartis Reports Q3 2024 Results
Oct 25Why Novartis Deserves Your Attention After Q2 2024 Results
Jul 19Novartis: Buy This Blue-Chip Dividend Stock On Sale Now
May 27Novartis Looks To Get Back On Track With Q1 Earnings
Apr 19New And Improved Novartis
Oct 30Novartis: Better Margin Visibility Ex-Sandoz
Oct 06Novartis: Buy This Dividend Aristocrat For Consistent Income
Sep 26Financial Position Analysis
Short Term Liabilities: NVS's short term assets ($31.3B) exceed its short term liabilities ($28.1B).
Long Term Liabilities: NVS's short term assets ($31.3B) do not cover its long term liabilities ($32.0B).
Debt to Equity History and Analysis
Debt Level: NVS's net debt to equity ratio (37.9%) is considered satisfactory.
Reducing Debt: NVS's debt to equity ratio has increased from 53.5% to 69.8% over the past 5 years.
Debt Coverage: NVS's debt is well covered by operating cash flow (52.7%).
Interest Coverage: NVS's interest payments on its debt are well covered by EBIT (57.1x coverage).